- Home
- HAIN vs PACB Comparison
HAIN vs PACB Comparison
Compare HAIN & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAIN
- PACB
- Stock Information
- Founded
- HAIN 1993
- PACB 2000
- Country
- HAIN United States
- PACB United States
- Employees
- HAIN N/A
- PACB N/A
- Industry
- HAIN Packaged Foods
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- HAIN Consumer Staples
- PACB Industrials
- Exchange
- HAIN Nasdaq
- PACB Nasdaq
- Market Cap
- HAIN 445.6M
- PACB 364.2M
- IPO Year
- HAIN 1993
- PACB 2010
- Fundamental
- Price
- HAIN $4.18
- PACB $1.54
- Analyst Decision
- HAIN Hold
- PACB Buy
- Analyst Count
- HAIN 8
- PACB 13
- Target Price
- HAIN $6.56
- PACB $2.79
- AVG Volume (30 Days)
- HAIN 2.0M
- PACB 14.1M
- Earning Date
- HAIN 02-10-2025
- PACB 02-13-2025
- Dividend Yield
- HAIN N/A
- PACB N/A
- EPS Growth
- HAIN N/A
- PACB N/A
- EPS
- HAIN N/A
- PACB N/A
- Revenue
- HAIN $1,663,238,000.00
- PACB $154,014,000.00
- Revenue This Year
- HAIN N/A
- PACB $22.84
- Revenue Next Year
- HAIN $2.22
- PACB $30.91
- P/E Ratio
- HAIN N/A
- PACB N/A
- Revenue Growth
- HAIN N/A
- PACB N/A
- 52 Week Low
- HAIN $3.28
- PACB $1.16
- 52 Week High
- HAIN $10.07
- PACB $6.09
- Technical
- Relative Strength Index (RSI)
- HAIN 36.49
- PACB 45.60
- Support Level
- HAIN $3.87
- PACB $1.27
- Resistance Level
- HAIN $4.60
- PACB $2.06
- Average True Range (ATR)
- HAIN 0.37
- PACB 0.21
- MACD
- HAIN 0.00
- PACB 0.03
- Stochastic Oscillator
- HAIN 50.28
- PACB 34.18
About HAIN Hain Celestial Group Inc. (The)
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas among others. It operates under two reportable segments; North America and International. The majority of its revenue is derived from the North America segment which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.